Type-1 Diabetes Induces Depot-Specific Alterations in Adipocyte Diameter and Mass of Adipose Tissues in the Rat

Abstract

Type-1 diabetes (T1D) is a metabolic disorder associated with massive reduction in mass of adipose tissue. Measuring cell diameter, an index of fat metabolism, we determined depot-specific alterations in weight of adipose tissue, fat cell diameter and size heterogeneity and distribution at 5 depots in streptozotocin (STZ)-induced diabetic rats. T1D was induced by a single injection of STZ. Seven days after the injection, fat depots were isolated, weighted, washed and maintained in tissue culture medium. Using a microscope equipped with calibrated micrometer, cell diameter as well as size distribution pattern and heterogeneity of adipocytes were determined in fresh tissue slices of subcutaneous (SC), proximal epididymal (PE), distal epididymal (DE), perirenal (PR) and retroperitoneal (RP) fat depots. The T1D induced marked reductions in fat mass and mean of fat cell diameter at all depots. The most affected depot was the SC. With the exception of PE, adipocytes at all depots showed significant increases in size heterogeneity. The effect of the diabetes on mean fat cell diameter and size heterogeneity was minimal at PE depot. Depots with similar cell size distribution pattern exhibited similar fat mass reduction. However, the DE depot with a unique cell size distribution pattern showed a fat mass reduction similar to that of PE and PR depots. These data indicate that T1D induces a massive fat mass reduction in a reasonably depot-specific manner and that the fat depots close to survival organs are less vulnerable to fat mobilization. Moreover, peculiar disagreement between cell size distribution and heterogeneity as well as the level of fat mass reduction at DE and PE depots suggests that not only cell size and heterogeneity but also local factors may play roles in depot-specific fat mobilization.

Key words

cell size - adipocyte - fat depots - diabetes - rat

References

• 1 Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues.  Ann Med. 1995;  27 435-438
• 2 Ashwell M, Priest P, Bondoux M. et al . Human fat cell sizing – a quick, simple method.  J Lipid Res. 1976;  17 190-192
• 3 Bastelica D, Morange P, Berthet B. et al . Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.  Arterioscler Thromb Vasc Biol. 2002;  22 173-178
• 4 Berger JJ, Barnard RJ. Effect of diet on fat cell size and hormone-sensitive lipase activity.  J Appl Physiol. 1999;  87 227-232
• 5 Despres JP, Moorjani S, Lupien PJ. et al . Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.  Arteriosclerosis. 1990;  10 497-511
• 6 Drolet R, Richard C, Sniderman AD. et al . Hypertrophy and hyperplasia of abdominal adipose tissues in women.  Int J Obes. 2008;  32 283-291
• 7 Farnier C, Krief S, Blache M. et al . Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway.  Int J Obes Relat Metab Disord. 2003;  27 1178-1186
• 8 Foster DW, Esser V. Ketoacidosis and hyperosmolar coma.. In: DeGroot L, Jameson JL, (eds.). Endocrinology. 5th edn. Philadelphia: Elsevier; 2006: 1185-1195
• 9 Fruhbeck G, Gomez-Ambrosi J. Depot-specific differences in the lipolytic effect of leptin on isolated white adipocytes.  Med Sci Monit. 2002;  8 47-55
• 10 Jernas M, Palming J, Sjoholm K. et al . Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression.  FASEB J. 2006;  20 832-839
• 11 Jo J, Gavrilova O, Pack S. et al . Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth.  PLoS Comput Biol. 2009;  5 e1000324
• 12 Kershaw EE, Flier JS. Adipose tissue as an endocrine organ.  J Clin Endocrinol Metab. 2004;  89 2548-2566
• 13 Laviola L, Perrini S, Cignarelli A. et al . Insulin signaling in human visceral and subcutaneous adipose tissue in vivo.  Diabetes. 2006;  55 952-961
• 14 Lemonnier D. Effect of age, sex, and site on the cellularity of the adipose tissue in mice and rats rendered obese by a high-fat diet.  J Clin Invest. 1972;  51 2907-2915
• 15 Montague CT, Prins JB, Sanders L. et al . Depot-related gene expression in human subcutaneous and omental adipocytes.  Diabetes. 1998;  47 1384-1391
• 16 Motoshima H, Wu X, Sinha MK. et al . Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone.  J Clin Endocrinol Metab. 2002;  87 5662-5667
• 17 Richelsen B, Pedersen SB, Moller-Pedersen T. et al . Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2.  Metabolism. 1991;  40 990-996
• 18 Sjostrom L, Bjorntorp P, Vrana J. Microscopic fat cell size measurements on frozen-cut adipose tissue in comparison with automatic determinations of osmium-fixed fat cells.  J Lipid Res. 1971;  12 521-530
• 19 Smith U. Effect of cell size on lipid synthesis by human adipose tissue in vitro.  J Lipid Res. 1971;  12 65-70
• 20 Spalding KL, Arner E, Westermark PO. et al . Dynamics of fat cell turnover in humans.  Nature. 2008;  453 783-787
• 21 Stolic M, Russell A, Hutley L. et al . Glucose uptake and insulin action in human adipose tissue – influence of BMI, anatomical depot and body fat distribution.  Int J Obes Relat Metab Disord. 2002;  26 17-23
• 22 Tavernier G, Galitzky J, Valet P. et al . Molecular mechanisms underlying regional variations of catecholamine-induced lipolysis in rat adipocytes.  Am J Physiol. 1995;  268 1135-1142
• 23 Tchernof A, Belanger C, Morisset AS. et al . Regional differences in adipose tissue metabolism in women minor effect of obesity and body fat distribution.  Diabetes. 2006;  55 1353-1360
• 24 Van Harmelen V, Lonnqvist F, Thorne A. et al . Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.  Int J Obes Relat Metab Disord. 1997;  21 972-979
• 25 Virtanen KA, Lonnroth P, Parkkola R. et al . Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans.  J Clin Endocrinol Metab. 2002;  87 3902-3910
• 26 Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.  Endocr Rev. 2000;  21 697-738
• 27 Wu X, Hoffstedt J, Deeb W. et al . Depot-specific variation in protein-tyrosine phosphatase activities in human omental and subcutaneous adipose tissue: a potential contribution to differential insulin sensitivity.  J Clin Endocrinol Metab. 2001;  86 5973-5980
• 28 Zierath JR, Livingston JN, Thorne A. et al . Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signaling through the insulin receptor substrate-1 pathway.  Diabetologia. 1998;  41 1343-1354
• 29 Zinder O, Shapiro B. Effect of cell size on epinephrine- and ACTH-induced fatty acid release from isolated fat cells.  J Lipid Res. 1971;  12 91-95

Correspondence